Children's cancers, Neuroblastoma
Results
Phase 2
This trial looked at a drug called 177 Lutetium DOTATATE (LuDO) to improve treatment for children and young people with neuroblastoma. It was for people whose cancer had come back or treatment had stopped working.
This trial was for children and young people up to the age of 18. We use the term 'you' in this summary, but of course if you are a parent, we are referring to your child.
Cancer Research UK supported this trial.
This trial was open for people to join between 2013 and 2017, and the team published the results in 2020.
Recruitment start: 19 September 2013
Recruitment end: 23 July 2017
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr Mark Gaze
Cancer Research UK
Biomedical Research Centre
Experimental Cancer Medicine Centre (ECMC)
Joining Against Cancer in Kids
National Institute for Health Research University College London Hospitals
NIHR Clinical Research Network: Cancer
University of Birmingham
This is Cancer Research UK trial number CRUK/11/031.
Last reviewed: 24 March 2021
CRUK internal database number: 8775
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
